Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (21)
Thomas Walter Georgi, Lars Kurch, Georg-Nikolaus Franke, Madlen Jentzsch, Sebastian Schwind, Carmen Perez-Fernandez, Naima Petermann, Maximilian Merz, Klaus Metzeler, Gudrun Borte, Sandra Hoffmann, Marco Herling, Timm Denecke, Regine Kluge, Osama Sabri, Uwe Platzbecker & Vladan Vučinić. (2023) Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy. Journal of Cancer Research and Clinical Oncology 149:9, pages 6131-6138.
Crossref
Crossref
Hua‐Jay J. Cherng, Guofan Xu, Lei Feng, Raphael Steiner, Luis Fayad, Paolo Strati, Ranjit Nair, Loretta J. Nastoupil, Hun Ju Lee, Sattva S. Neelapu, Christopher R. Flowers, Maria Rodriguez, Michael Wang, Fredrick Hagemeister, Chelsea C. Pinnix, Jeremy Ramdial, Samer Srour, Yago Nieto, Katayoun Rezvani, Richard Champlin, Partow Kebriaei, Jason Westin, Homer A. Macapinlac, Elizabeth Shpall & Sairah Ahmed. (2022) Positron emission tomography derived metrics in relapsed or refractory large B‐cell lymphoma with residual disease before autologous stem cell transplant. British Journal of Haematology 200:1, pages 35-44.
Crossref
Crossref
David L. Raunig, Gene A. Pennello, Jana G. Delfino, Andrew J. Buckler, Timothy J. Hall, Alexander R. Guimaraes, Xiaofeng Wang, Erich P. Huang, Huiman X. Barnhart, Nandita deSouza & Nancy Obuchowski. (2022) Multiparametric Quantitative Imaging Biomarker as a Multivariate Descriptor of Health: A Roadmap. Academic Radiology.
Crossref
Crossref
Thomas W Georgi, Axel Zieschank, Kevin Kornrumpf, Lars Kurch, Osama Sabri, Dieter Körholz, Christine Mauz-Körholz, Regine Kluge & Stefan Posch. (2022) Automatic classification of lymphoma lesions in FDG-PET–Differentiation between tumor and non-tumor uptake. PLOS ONE 17:4, pages e0267275.
Crossref
Crossref
Christina Messiou, Nuria Porta, Bhupinder Sharma, Daniel Levine, Dow-Mu Koh, Kevin Boyd, Charlotte Pawlyn, Angela Riddell, Katherine Downey, James Croft, Veronica Morgan, Simon Stern, Betty Cheung, Charalampia Kyriakou, Pawel Kaczmarek, Jessica Winfield, Matthew Blackledge, Wim J. G. Oyen & Martin F. Kaiser. (2021) Prospective Evaluation of Whole-Body MRI versus FDG PET/CT for Lesion Detection in Participants with Myeloma. Radiology: Imaging Cancer 3:5, pages e210048.
Crossref
Crossref
Leonardo CAMPIOTTI, Diego DE PALMA, Luigina GUASTI, Ilaria PROSERPIO, Sabrina CASAGRANDE, Ilaria SCHIORLIN, Elena BOLZACCHINI, Matteo SUTER, Francesca OGLIARI & Alessandro SQUIZZATO. (2021) Baseline PET as prognostic index in diffuse large B-cell lymphoma and grade IIIb follicular lymphoma: a retrospective study of a single-center experience. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 65:1.
Crossref
Crossref
Emanuele Zucca, Luciano Cascione, Teresa Ruberto, Davide Facchinelli, Sämi Schär, Stefanie Hayoz, Stefan Dirnhofer, Luca Giovanella, Mario Bargetzi, Christoph Mamot & Luca Ceriani. (2020) Prognostic models integrating quantitative parameters from baseline and interim positron emission computed tomography in patients with diffuse large B‐cell lymphoma: post‐hoc analysis from the SAKK38/07 clinical trial. Hematological Oncology 38:5, pages 715-725.
Crossref
Crossref
Anne-Victoire Michaud-Robert, Elena Zamagni, Thomas Carlier, Clément Bailly, Bastien Jamet, Cyrille Touzeau, Philippe Moreau, Françoise Kraeber-Bodere, Cristina Nanni & Caroline Bodet-Milin. (2020) Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase III Trials. Cancers 12:9, pages 2532.
Crossref
Crossref
Charline Lasnon, Nicolas Coudrais, Benjamin Houdu, Catherine Nganoa, Thibault Salomon, Blandine Enilorac & Nicolas Aide. (2020) How fast can we scan patients with modern (digital) PET/CT systems?. European Journal of Radiology 129, pages 109144.
Crossref
Crossref
Thomas W. Georgi, Lars Kurch, Dirk Hasenclever, Victoria S. Warbey, Lucy Pike, John Radford, Osama Sabri, Regine Kluge & Sally F. Barrington. (2020) Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trial. PLOS ONE 15:4, pages e0231027.
Crossref
Crossref
Luca Ceriani, Giuseppe Gritti, Luciano Cascione, Maria Cristina PirosaAngela PolinoTeresa RubertoAnastasios StathisAndrea BrunoAlden A. MocciaLuca Giovanella, Stefanie Hayoz, Sämi SchärStefan DirnhoferAlessandro Rambaldi, Giovanni MartinelliChristoph Mamot & Emanuele Zucca. (2020) SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model. Blood Advances 4:6, pages 1082-1092.
Crossref
Crossref
Clément Bailly, Thomas Carlier, Bastien Jamet, Cyrille Touzeau, Philippe Moreau, Françoise Kraeber-Bodéré & Caroline Bodet-Milin. (2019) 18F-FDG PET/CT in multiple myeloma: critical insights and future directions. European Journal of Nuclear Medicine and Molecular Imaging 46:5, pages 1048-1050.
Crossref
Crossref
Egesta Lopci & Michel Meignan. (2018) Deauville score: the Phoenix rising from ashes. European Journal of Nuclear Medicine and Molecular Imaging 46:5, pages 1043-1045.
Crossref
Crossref
Clément Bailly, Thomas Carlier, Cyrille Touzeau, Nicolas Arlicot, Françoise Kraeber-Bodéré, Steven Le Gouill & Caroline Bodet-Milin. (2019) Interest of FDG-PET in the Management of Mantle Cell Lymphoma. Frontiers in Medicine 6.
Crossref
Crossref
Iuliana Vaxman, Hanna Bernstine, Geffen Kleinstern, Natav Hendin, Shai Shimony, Liran Domachevsky, Ronit Gurion, David Groshar, Pia Raanani & Anat Gafter‐Gvili. (2019) FDG PET/CT as a diagnostic and prognostic tool for the evaluation of marginal zone lymphoma. Hematological Oncology 37:2, pages 168-175.
Crossref
Crossref
Clément Bailly, Thomas Carlier, Bastien Jamet, Thomas Eugene, Cyrille Touzeau, Michel Attal, Cyrille Hulin, Thierry Facon, Xavier Leleu, Aurore Perrot, Laurent Garderet, Margaret Macro, Denis Caillot, Philippe Moreau, Françoise Kraeber-Bodéré & Caroline Bodet-Milin. (2018) Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM Study. Clinical Cancer Research 24:21, pages 5219-5224.
Crossref
Crossref
Nicolas Aide, Thibault Salomon & Charline Lasnon. (2018) Reply to the Letter to the Editor from Peters et al: On the use of the liver as a reference organ for Deauville scoring in lymphoma patients and how it may be affected by liver steatosis. European Journal of Nuclear Medicine and Molecular Imaging 45:12, pages 2233-2234.
Crossref
Crossref
Nicolas Aide, Charline Lasnon & Gandhi Damaj. (2018) Combining baseline TMTV and gene profiling for a better risk stratification in diffuse large B cell lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 45:5, pages 677-679.
Crossref
Crossref
Cristina Nanni, Annibale Versari, Stephane Chauvie, Elisa Bertone, Andrea Bianchi, Marco Rensi, Marilena Bellò, Andrea Gallamini, Francesca Patriarca, Francesca Gay, Barbara Gamberi, Pietro Ghedini, Michele Cavo, Stefano Fanti & Elena Zamagni. (2017) Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe). European Journal of Nuclear Medicine and Molecular Imaging 45:5, pages 712-719.
Crossref
Crossref
Hugo J. A. Adams & Thomas C. Kwee. (2017) Interim FDG-PET in lymphoma, a questionable practice in hematology. European Journal of Nuclear Medicine and Molecular Imaging 44:12, pages 2014-2017.
Crossref
Crossref
Sally F. Barrington & Regine Kluge. (2017) FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas. European Journal of Nuclear Medicine and Molecular Imaging 44:S1, pages 97-110.
Crossref
Crossref